321 related articles for article (PubMed ID: 34959323)
1. Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review.
Buya AB; Witika BA; Bapolisi AM; Mwila C; Mukubwa GK; Memvanga PB; Makoni PA; Nkanga CI
Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959323
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
Singh J; Garg T; Rath G; Goyal AK
Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212
[TBL] [Abstract][Full Text] [Related]
4. Approaches for designing and delivering solid lipid nanoparticles of distinct antitubercular drugs.
Vasam M; Goulikar RK
J Biomater Sci Polym Ed; 2023 Apr; 34(6):828-843. PubMed ID: 36341573
[TBL] [Abstract][Full Text] [Related]
5. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies.
Kumar M; Virmani T; Kumar G; Deshmukh R; Sharma A; Duarte S; Brandão P; Fonte P
Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895831
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis Treatment Facilitated by Lipid Nanocarriers: Can Inhalation Improve the Regimen?
Hädrich G; Boschero RA; Appel AS; Falkembach M; Monteiro M; da Silva PEA; Dailey LA; Dora CL
Assay Drug Dev Technol; 2020 Oct; 18(7):298-307. PubMed ID: 33054379
[No Abstract] [Full Text] [Related]
8. Nano-based drug delivery optimization for tuberculosis treatment: A review.
Dahanayake MH; Jayasundera ACA
J Microbiol Methods; 2021 Feb; 181():106127. PubMed ID: 33359155
[TBL] [Abstract][Full Text] [Related]
9. Current therapeutic delivery approaches using nanocarriers for the treatment of tuberculosis disease.
Biswas B; Misra TK; Ray D; Majumder T; Bandyopadhyay TK; Bhowmick TK
Int J Pharm; 2023 Jun; 640():123018. PubMed ID: 37149113
[TBL] [Abstract][Full Text] [Related]
10. Nanostructured drug delivery for better management of tuberculosis.
Kaur IP; Singh H
J Control Release; 2014 Jun; 184():36-50. PubMed ID: 24732260
[TBL] [Abstract][Full Text] [Related]
11. Nano-antimicrobials: A New Paradigm for Combating Mycobacterial Resistance.
Minakshi P; Ghosh M; Brar B; Kumar R; Lambe UP; Ranjan K; Manoj J; Prasad G
Curr Pharm Des; 2019; 25(13):1554-1579. PubMed ID: 31218956
[TBL] [Abstract][Full Text] [Related]
12. Development of Lipid Nanocarriers for Tuberculosis Treatment: Evaluation of Suitable Excipients and Nanocarriers.
Hädrich G; Vaz GR; Boschero R; Appel AS; Ramos C; Halicki PCB; Bidone J; Teixeira HF; Muccillo-Baisch AL; Dal-Bó A; Silva Pinto L; Dailey LA; Da Silva PEA; Ramos DF; Dora CL
Curr Drug Deliv; 2021; 18(6):770-778. PubMed ID: 33583376
[TBL] [Abstract][Full Text] [Related]
13. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.
Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658
[TBL] [Abstract][Full Text] [Related]
14. Advanced drug delivery and therapeutic strategies for tuberculosis treatment.
Nair A; Greeny A; Nandan A; Sah RK; Jose A; Dyawanapelly S; Junnuthula V; K V A; Sadanandan P
J Nanobiotechnology; 2023 Nov; 21(1):414. PubMed ID: 37946240
[TBL] [Abstract][Full Text] [Related]
15. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
[TBL] [Abstract][Full Text] [Related]
16. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis.
Kaur M; Garg T; Rath G; Goyal AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(1):49-88. PubMed ID: 24579767
[TBL] [Abstract][Full Text] [Related]
17. Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool.
Thakur K; Sharma G; Singh B; Katare OP
Curr Pharm Des; 2018; 24(43):5108-5128. PubMed ID: 30657036
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
[TBL] [Abstract][Full Text] [Related]
19. Nano-carriers for the Treatment of Tuberculosis.
Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
